Stanford Accelerated Recovery Trial (START)

The goal of this study is to determine whether administering Gabapentin prior to surgery affects duration of pain and opioid use post-surgery. The investigators aim to compare gabapentin to placebo in a prospective, randomized clinical trial in which patients will be followed post-surgery until pain resolves and opioid use ceases.

Stanford is now accepting new patients for this trial. Please contact Debra Clay at 650-724-1753 for more information.



  • drug : Placebo
  • drug : Gabapentin

Phase: Phase 3


Ages Eligible For Study:

18 Years - 75 Years

Inclusion Criteria

1. Age 18-75 2. Undergoing a scheduled surgery 3. English speaking 4. Ability and willingness to complete questionnaires or use palm pilot

External Links

Explore related trials

Contact information

Primary Contact:

Debra Clay 650-724-1753

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: